Behavioral Economics to Improve Flu Vaccination Using EHR Nudges
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia and Seattle, United StatesSee the 2 sites
- Trial code
- Status
- Completed
- People taking part
- 80,039 people enrolled
- Started
- 25 Sept 2023
- Ended
- 20 May 2024
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Pre-visit patient text messaging
- Default pended order
- Monthly peer comparison feedback
- High risk bidirectional pre-visit text messaging
- Record updated
- 27 April 2025
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Other criteria
- Patient Inclusion Criteria:
- All patients must meet the following criteria to be eligible:
- Age >50 years
- A scheduled new or return (non-urgent/sick) primary care appointment at one of the study practices at the Penn Medicine, UW Medicine, or Lancaster General Hospital
- Have not received their annual flu vaccine during the active intervention period (September- February)
- Eligible to receive the flu vaccine; For the high risk intensification nudge, at least one of the following criteria must be met to be considered high risk and randomized to receive the intensification nudge:
- Age ≥ 70 years
- Living in a lower income community (lowest quartile, zip-code based)
- Did not receive a flu vaccine in the previous calendar year
- Self-identifies as Non-Hispanic Black; Patient Exclusion Criteria:
- Have a documented allergy to flu vaccine
- Have a flu vaccine exclusion modifier in Health Maintenance
- Have opted out of research according to individual site guidelines and policies
- Have no phone number (home or mobile) listed in their chart; Clinician Inclusion Criteria:; Clinicians must meet the following criteria to be eligible to receive peer comparison feedback:
- Practicing physician (MD, DO) or advanced practice provider (NP, PA) with the exception of residents and fellows
- Have a minimum patient panel of at least 50 patients, and
- Practicing at a clinical site randomized to receive the clinic-level nudge interventions
Where in United States
- University of Pennsylvania Health SystemPhiladelphia, United States
- University of WashingtonSeattle, United States
About the trial
What the trial wants to find out
This study will be a multisite, cluster randomized, pragmatic trial to evaluate the effectiveness of personalized nudges to clinicians and patients, relative to a control, to increase flu vaccination rates among older adults in accordance with CDC guidelines. This will include clinician and patient level nudge interventions, with an additional, intensified nudge intervention for patients identified as high risk for not receiving a flu vaccine. Among the intervention clinics, patients will receive pre-visit text message reminders about the flu vaccine, and clinicians will receive a default pended order in the visit encounter in the EHR, along with monthly peer comparison feedback about their flu vaccine completion rate. Patients identified as high risk for noncompletion will be individually randomized to receive an additional bidirectional text message nudge or the standard text messaging.
The 3 groups in the trial
- ControlNo study treatment, for comparison
Clinics randomized to the control arm will receive standard of care.
- Intervention ArmTreatment being tested
Clinics randomized to the intervention arm will receive the toolkit of clinician and patient facing nudges. Patient nudges will be pre-visit text message reminders (standard messaging content). Clinician nudges will be monthly peer comparison feedback and default pended orders.
Treatment: Pre-visit patient text messaging, Default pended order, and Monthly peer comparison feedback
- High Risk Intensification ArmTreatment being tested
Patients in the intervention clinics identified as high risk for noncompletion of the flu vaccine will be randomized 1:1 to receive the high risk intensification arm or remain in the standard intervention arm. Patients in the high risk intensification arm will receive an additional bidirectional texting component.
Treatment: Pre-visit patient text messaging, Default pended order, Monthly peer comparison feedback, and High risk bidirectional pre-visit text messaging
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- BE IMMUNE: Behavioral Economics to IMprove and Motivate Vaccination Using Nudges Through the EHR
- Publications
- Nudges to Clinicians and Patients for Influenza Vaccines During Visits: The BE IMMUNE Randomized Clinical Trial.JAMA internal medicine, 2026
- Behavioural economics to improve and motivate vaccination in primary care using nudges through the electronic health record: rationale and design of the BE IMMUNE randomised clinical trial.BMJ open, 2024
- Record updated
- 27 April 2025